Oita University to Begin PI Study for Replicon RNA Vaccine in October

Komeito Hearing on Replicon RNA Vaccine on Sept. 9 Oita University plans to start a first-in-human PI clinical trial for its replicon RNA vaccine against COVID-19 in the middle of October. It hopes to confirm the vaccine’s safety and immunogenicity...read more